Supplementary Data for Cardiac Hydrogel and Astragaloside IV Therapy Study

A 539.1 KB supplementary document details a study on a heart-derived hydrogel for localized drug delivery. The research, authored by Yanxing Lan and uploaded to figshare in April 2026, investigates the synergistic effects of Astragaloside IV and a porcine heart extracellular matrix hydrogel on vascular regeneration in a rat myocardial infarction model.

Use Cases

• Analyze proteomic data and network pharmacology results to identify activated signaling pathways like EGFR/Raf-MEK-ERK.
• Review experimental parameters for the rat myocardial infarction model, including treatment administration methods and functional outcome measures.
• Extract quantitative data on endothelial cell survival, migration, and angiogenic capacity under oxygen-glucose deprivation conditions.
• Examine fabrication details for the decellularized porcine heart extracellular matrix hydrogel and its drug release kinetics.

Strengths

• Dataset is openly licensed under CC-BY-4.0, enabling reuse and redistribution.
• Document is recent, last updated in April 2026, indicating contemporary research.

Limitations

• The dataset is very small at 539.1 KB, containing a single supplementary document, not a large-scale data repository.
• Data is presented in a DOCX file, requiring extraction and parsing of embedded text, tables, or figures for computational analysis.
• Specific sample sizes, raw numerical data, and columnar data structures are not explicitly defined in the provided description.

Provenance

Source

figshare, authored by Yanxing Lan.

Collection Method

Experimental research involving in vitro cell studies and a rat model of myocardial infarction, with integrative proteomic and network pharmacology analysis.

Time Range

Study period not specified; document uploaded in 2026.

Freshness

Last updated 2026-04-08.

Geography

null